Contrast-Induced Nephropathy and Long-Term Adverse Events | Zendy

Richard Solomon | Zendy; Roxana Mehran | Zendy; Madhu Natarajan | Zendy; Serge Doucet | Zendy; Richard E. Katholi | Zendy; Cezar Staniloae | Zendy; Sanjeev Sharma | Zendy; Marino Labinaz | Zendy; Joseph Gelormini | Zendy; Brendan J. Barrett | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Contrast-Induced Nephropathy and Long-Term Adverse Events

Author(s) -

Richard Solomon,

Roxana Mehran,

Madhu Natarajan,

Serge Doucet,

Richard E. Katholi,

Cezar Staniloae,

Sanjeev Sharma,

Marino Labinaz,

Joseph Gelormini,

Brendan J. Barrett

Publication year - 2009

Publication title -

clinical journal of the american society of nephrology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.755

H-Index - 151

eISSN - 1555-905X

pISSN - 1555-9041

DOI - 10.2215/cjn.00550109

Subject(s) - medicine , contrast induced nephropathy , iopamidol , incidence (geometry) , nephropathy , poisson regression , rate ratio , adverse effect , randomized controlled trial , iodixanol , randomization , confidence interval , contrast medium , diabetes mellitus , radiology , population , physics , environmental health , optics , endocrinology

The relationship of contrast-induced nephropathy (CIN) to long-term adverse events (AEs) is controversial. Although an association with AEs has been previously reported, it is unclear whether CIN is causally related to these AEs.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research